Based on this observation, and on the impaired resolution of inflammation known to occur in Alzheimer’s disease, we decided to analyze whether CCL2 modulates the resolution of inflammation in the brain. The gene discussed is CCL2; the disease is early-onset autosomal dominant Alzheimer disease.